drugset / Trial / NCT01608880

Effect of Nitroglycerin Ointment on Mastectomy Flap Necrosis

NCT01608880

Completed 154 enrolled University of British Columbia
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Background: Mastectomy flap necrosis (MFN) is a common complication that affects recovery, reconstructive success and aesthetic outcome. Nitroglycerin (NTG) ointment is a potent topical vasodilator that increases local blood flow by dilating arteries and veins without altering the ratio of pre- to post-capillary resistance. There are no studies that evaluate whether the application of NTG ointment in patients undergoing Skin-sparing mastectomy (SSM) or nipple-sparing mastectomy (NSM) and immediate reconstruction decreases the rate of mastectomy flap necrosis. Objective: To evaluate if the post-operative application of NTG ointment improve rates of MFN in patients undergoing SSM or NSM with immediate breast reconstruction compared to patients receiving placebo. Hypothesis: In patients undergoing SSM and immediate breast reconstruction there will be a decrease in the rate of MFN in those who receive NTG ointment compared to those who receive placebo.

Timeline

Start
2012-08
Primary completion
2014-03
Completion
2014-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitroglycerin Unknown 45 mg Topical

Indications